Early detection and continuous care have become essential in managing schizophrenia and psychotic disorders, which often emerge during adolescence or early adulthood. Recent advances highlight the importance of coordinated specialty care, combining antipsychotic medication, social support, and cognitive behavioral therapy. Neuroimaging and genetic studies continue to uncover biomarkers linked to psychotic symptoms, improving diagnostic accuracy. Innovations such as digital monitoring tools and long-acting injectable medications enhance treatment adherence and functional outcomes. Psychosocial rehabilitation remains a cornerstone, helping individuals build life skills, re-enter the workforce, and maintain meaningful relationships. Integrating neuroscience, clinical care, and social services offers a more holistic approach to sustained recovery.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Evaluation of prevalence and pattern of tobacco use in yenagoa city in bayelsa state south of nigeria
Owonaro Peter, Bayelsa State Drug Avuse Addiction Prevention and Rehabilitation Committee (BADAPARC), Nigeria
Title : Engaging learners through gamification, creativity, and human-centered design
Tero Moliis, Versantium, United States
Title : Neuropharmacological and regulatory drivers of tianeptine misuse in the united states: A growing public health concern
Darcy Tocci, NSU College of Pharmacy, United States
Title : Awakening sovereignty within: Healing trauma, releasing codependency, and returning to self-trust
Whitney Walker, Mental Health Therapist/ Podcast Host, United States
Title : You can save a life: Real conversations, real solutions for suicide prevention
frank King, The Mental Health Comedian, LLC, United States